Origin Biosciences
BioTech/Drugs - Palo Alto, CA, US
Origin Biosciences Employees
Origin Biosciences Details
Origin Biosciences, a subsidiary of BridgeBio Pharma, is a biotechnology company focused treatment for Molybdenum Cofactor Deficiency (MoCD). Origin is led by a team of veteran biotechnology executives. Together with patients and physicians, the company aims to bring a safe, effective treatment for MoCD to market as quickly as possible.
Website:
origintx.com
Employees:
20 - 49
HQ:
617-322-5165
Location:
Palo Alto, CA, US
Revenue:
2.5 - 5 Million
Origin Biosciences Technologies
Email Providers
Outlook
Tag Management
Google Tag Manager
Email Delivery
Rackspace MailGun
Other
Microsoft Office 365
Hosting
Microsoft Azure Hosting
Online Video Platforms
Vimeo